Pacific Biosciences of California (PACB) said Tuesday it was selected by the Davos Alzheimer's Collaborative as a technology partner for its North African Dementia Registry project.
The partnership will utilize Pacific Biosciences of California's sequencing technology to develop genetic insights into the factors contributing to Alzheimer's disease and dementia for future research, prevention, and treatment efforts, according to a company statement.
The collaboration is expected to address the underrepresentation of North African populations in dementia research and build a comprehensive dataset to further the research community's understanding of the disease, the company said.
Shares were up over 2% in recent Tuesday trading.
Price: 1.17, Change: +0.03, Percent Change: +2.63
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。